Cardioblate CryoFlex, Surgical Ablation Probe, Model Number 60SF7, PROBE 60SF7 CRYOFLEX 7CM 26L -...
FDA Device Recall #Z-0495-2021 — Class II — October 12, 2020
Recall Summary
| Recall Number | Z-0495-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 12, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | MEDTRONIC ATS MEDICAL, INC. |
| Location | Plymouth, MN |
| Product Type | Devices |
| Quantity | 15 units |
Product Description
Cardioblate CryoFlex, Surgical Ablation Probe, Model Number 60SF7, PROBE 60SF7 CRYOFLEX 7CM 26L - is a single use, disposable cryoprobe that is designed for use with the CryoFlex Surgical Ablation System. The probe has an integrated thermocouple for monitoring temperature at its ablation segment.
Reason for Recall
There is a potential defect in the seals of the sterile barrier pouch used to package the CryoFlex disposables devices
Distribution Pattern
Worldwide distribution - US Nationwide distribution and the countries of Belgium, Czech Republic, Germany, Korea.
Lot / Code Information
Model Number 60SF7, GTIN 00763000114633, Serial Numbers: 17720000, 17720001, 17720002, 17720011, 17720012, 17720013, 17720014, 17720015, 17720016, 17720017, 17720018, 17720019, 17720020, 17720021, 20620000
Other Recalls from MEDTRONIC ATS MEDICAL, INC.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0496-2021 | Class II | Cardioblate CryoFlex, Surgical Ablation Probe, ... | Oct 12, 2020 |
| Z-0493-2021 | Class II | Cardioblate CryoFlex, Surgical Ablation Probe, ... | Oct 12, 2020 |
| Z-0494-2021 | Class II | Cardioblate CryoFlex, Surgical Ablation Probe, ... | Oct 12, 2020 |
| Z-1533-2020 | Class II | Medtronic Open Pivot Aortic Valve Graft, REF 50... | Feb 11, 2020 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.